Prospective validation of the prognostic 31‐gene expression profiling test in primary cutaneous melanoma

BACKGROUND: Gene expression profiling (GEP) has been integrated into cancer treatment decision‐making in multiple neoplasms. We prospectively evaluated the prognostic utility of the 31‐GEP test (DecisionDx‐Melanoma, Castle Biosciences, Inc) in cutaneous melanoma (CM) patients undergoing sentinel nod...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Keller, Jennifer, Schwartz, Theresa L., Lizalek, Jason M., Chang, Ea‐sle, Patel, Ashaki D., Hurley, Maria Y., Hsueh, Eddy C.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6536922/
https://ncbi.nlm.nih.gov/pubmed/30950242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2128
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados